| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 22, 2026 | ±1.8% | -0.4% | over-priced |
| October 16, 2025 | ±2.0% | -0.7% | over-priced |
| July 23, 2025 | ±2.8% | -0.7% | over-priced |
| April 16, 2025 | ±4.2% | -2.0% | over-priced |
| October 17, 2024 | ±1.8% | -6.7% | under-priced |
| August 5, 2024 | ±2.5% | -3.2% | under-priced |
| April 18, 2024 | ±1.9% | +0.7% | over-priced |
| October 20, 2023 | ±1.9% | +0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.43 | $3.5B | $807M |
| Q4 FY2025 | $0.38 | $3.5B | $720M |
| Q3 FY2025 | $0.37 | $3.6B | $694M |
| Q2 FY2025 | $0.44 | $3.6B | $829M |
CSX Corporation (CSX) reports in 86 days, with the next report estimated for September 7, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced CSX's earnings risk. Fundamentals into the print: EPS up 26.5% year-over-year, revenue up 1.7%. QuantLogix's live 5-factor engine currently reads CSX as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →